Clinical Trial Update: Doripenem in the Treatment of Complicated Intra-Abdominal Infections [Phase 3]

View source ↗

Summary

Phase 3 trial of Doripenem for complicated intra-abdominal infections has completed, evaluating conditions including appendicitis, cholecystitis, pancreatitis, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendicitis
• Cholecystitis
• Pancreatitis
• Peritonitis

Drugs mentioned

• Doripenem (Doripenem)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bacterial Infections and Mycoses, Appendicitis | Phase 3 | Status: COMPLETED